Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
LadRx Corp operates as a biopharmaceutical research and development company in the healthcare sector of the United States. It is focused on the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company develops Aldoxorubicin, which is meant to cure soft tissue sarcoma, a kind of tumor. It also develops Arimoclomol which is in development in Niemann Pick disease Type C (NPC) and Gaucher disease.
| Last: | $0.11 |
|---|---|
| Change Percent: | 266.67% |
| Open: | $0.11 |
| Close: | $0.03 |
| High: | $0.11 |
| Low: | $0.11 |
| Volume: | 1,019 |
| Last Trade Date Time: | 02/24/2026 10:35:59 am |
| Market Cap: | $51,242 |
|---|---|
| Float: | 448,553 |
| Insiders Ownership: | 11.11% |
| Institutions: | 3 |
| Short Percent: | 294308% |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | http://www.ladrxcorp.com |
| Country: | US |
| City: | Los Angeles |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about LadRx Corp (OTCMKTS: LADX).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
